Form 4: Director Meenu Chhabra Trades Macrogenics Stock

Director Meenu Chhabra reported transactions involving Macrogenics Inc. common stock, including the acquisition of restricted stock units and the disposal of common stock.

Summary

• Director Meenu Chhabra engaged in several transactions related to Macrogenics Inc. common stock.
• On May 18, 2026, 3,750 restricted stock units (RSUs) vested, which were previously granted.
• Following these transactions, the reporting person beneficially owns 14,750 shares of common stock.
• A stock option to purchase 22,000 shares of common stock at an exercise price of $4.52 was acquired, with vesting commencing one month from the grant date and exercisable until May 19, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine insider transactions related to equity compensation rather than significant strategic shifts or financial performance indicators.

Positives

• Director Meenu Chhabra acquired 3,750 restricted stock units, indicating continued equity participation.
• A stock option for 22,000 shares was acquired, providing potential future upside.

Negatives

• The filing indicates a disposal of 3,750 shares of common stock, though the context suggests this is related to RSU vesting and settlement.

Future Outlook

The acquired stock option for 22,000 shares at an exercise price of $4.52, with vesting starting monthly and exercisable until May 19, 2036, suggests a long-term outlook on the company's stock performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and trading activities of company directors and officers. These filings are crucial for investors seeking to understand management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders: The filing provides transparency into director equity holdings and transactions, which can inform investment decisions.
• Employees: The vesting of RSUs and acquisition of stock options are part of employee compensation structures.

Next Steps

• The stock option acquired on May 19, 2026, will vest in monthly increments.
• The reporting person will continue to beneficially own 14,750 shares of common stock.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Macrogenics Inc., MGNX, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Transactions